Q: What is the SEER Summary stage for a patient diagnosed with metastatic disease to the bone and brain but a primary site is not identified (C80.9) – Unknown Primary Site. A: Code 9 – Unknown. Per the Seer Summary Stage manual, page 281, the stage would be unknown as the primary site is unknown/not stated therefore the summary stage cannot be determined. Q: In…
Q&A: Radiation Coding
Q: A breast cancer receives a modified radical mastectomy and is referred for subsequent radiation therapy. The patient receives 5000 cgy in 25 fxs to the left chest wall and 1000 cgy in 5 fxs as a boost to the chest wall scar. What is the code for the radiation treatment volume? A: Code 20 Chest Wall. Per FORDS page 240, code 20 encompasses the chest…
What are your 2015 Program Goals?
New Years Eve is an opportunity to reflect on the past year and apply all that has occurred for the new year. Our consultants enjoy sharing our favorite movies, books, new opportunities, recipes, accomplishments, and embarrassing moments amongst family and friends. Our answers bring laughter and learning and even soul-searching but it’s always a great opportunity to appreciate the year and all it had to offer….
Consultant Spotlight: Kellie Garland, CTR
Kellie Garland, CTR serves as Project Director for the Oncology Services Division of Registry Partners Incorporated. Kellie is tasked with overseeing and directing state incidence reporting projects, focusing her efforts on new project implementation as well as mentoring existing and new state incidence reporting project managers and project specialists. She presently resides in Franklin, PA and has a daughter, Meagan, a son, Nathaniel, and three grandchildren. Garland…